The HOPE Asia Network consensus on blood pressure measurements corresponding to office measurements: Automated office, home, and ambulatory blood pressures.
ambulatory blood pressure/home blood pressure monitor
antihypertensive therapy
corresponding blood pressures
hypertension guidelines
masked uncontrolled hypertension
white-coat hypertension
Journal
Journal of clinical hypertension (Greenwich, Conn.)
ISSN: 1751-7176
Titre abrégé: J Clin Hypertens (Greenwich)
Pays: United States
ID NLM: 100888554
Informations de publication
Date de publication:
25 Oct 2023
25 Oct 2023
Historique:
revised:
28
07
2023
received:
06
04
2023
accepted:
06
09
2023
medline:
25
10
2023
pubmed:
25
10
2023
entrez:
25
10
2023
Statut:
aheadofprint
Résumé
For adopting recently introduced hypertension phenotypes categorized using office and out of office blood pressure (BP) for the diagnosis of hypertension and antihypertension drug therapy, it is mandatory to define the corresponding out of office BP with the specific target BP recommended by the major guidelines. Such conditions include white-coat hypertension (WCH), masked hypertension (MH), white-coat uncontrolled hypertension (WUCH), and masked uncontrolled hypertension (MUCH). Here, the authors review the relevant literature and discuss the related issue to facilitate the use of corresponding BPs for proper diagnosis of WCH, MH, WUCH, and MUCH in the setting of standard target BP as well as intensive target BP. The methodology of deriving the corresponding BP has evolved from statistical methods such as standard deviation, percentile value, and regression to an outcome-based approach using pooled international cohort study data and comparative analysis in randomized clinical trials for target BPs such as the SPRINT and STEP studies. Corresponding BPs to 140/90 and 130/80 mm Hg in office BP is important for safe and strict achievement of intensive BP targets. The corresponding home, daytime, and 24-h BPs to 130/80 mm Hg in office BP are 130/80, 130/80, and 125/75 mm Hg, respectively. However, researchers have found some discrepancies among the home corresponding BPs. As tentative criterion for de-escalation of antihypertensive therapy as shown in European guidelines was 120 mm Hg in office BP, corresponding home, daytime, and 24-h systolic BPs to 120 mm Hg in office systolic BP are 120, 120, and 115 mm Hg, respectively.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC.
Références
Collaborators GBDRF. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1223-1249. doi:10.1016/S0140-6736(20)30752-2
Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021-3104. doi:10.1093/eurheartj/ehy339
Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71(19):e127-e248. doi:10.1016/j.jacc.2017.11.006
Kim BK, Rhee MY. Impact of 2018 ESC/ESH and 2017 ACC/AHA hypertension guidelines: difference in prevalence of white-coat and masked hypertension. Healthcare (Basel). 2020;8(2):122. doi:10.3390/healthcare8020122
Bo Y, Kwok KO, Chu KK, et al. Comparison between automated office blood pressure measurements and manual office blood pressure measurements-implications in individual patients: a systematic review and meta-analysis. Curr Hypertens Rep. 2021;23(1):4. doi:10.1007/s11906-020-01118-1
Kario K. Global impact of 2017 American Heart Association/American College of Cardiology Hypertension guidelines: a perspective from Japan. Circulation. 2018;137(6):543-545. doi:10.1161/CIRCULATIONAHA.117.032851
Umemura S, Arima H, Arima S, et al. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2019). Hypertens Res. 2019;42(9):1235-1481. doi:10.1038/s41440-019-0284-9
Masugata H, Senda S, Inukai M, et al. Clinical significance of differences between home and clinic systolic blood pressure readings in patients with hypertension. J Int Med Res. 2013;41(4):1272-1280. doi:10.1177/0300060513485863
Thijs L, Staessen JA, Celis H, et al. Reference values for self-recorded blood pressure: a meta-analysis of summary data. Arch Intern Med. 1998;158(5):481-488. doi:10.1001/archinte.158.5.481
Kikuya M, Hansen TW, Thijs L, et al. Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk. Circulation. 2007;115(16):2145-2152. doi:10.1161/CIRCULATIONAHA.106.662254
Staessen JA, Fagard RH, Lijnen PJ, Thijs L, Van Hoof R, Amery AK. Mean and range of the ambulatory pressure in normotensive subjects from a meta-analysis of 23 studies. Am J Cardiol. 1991;67(8):723-727. doi:10.1016/0002-9149(91)90529-t
Staessen JA, O'Brien ET, Amery AK, et al. Ambulatory blood pressure in normotensive and hypertensive subjects: results from an international database. J Hypertens Suppl. 1994;12(7):S1-12.
Staessen JA, Bieniaszewski L, O'Brien ET, Imai Y, Fagard R. An epidemiological approach to ambulatory blood pressure monitoring: the Belgian population study. Blood Press Monit. 1996;1(1):13-26.
Mancia G, Sega R, Bravi C, et al. Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens. 1995;13(12 Pt 1):1377-1390.
Imai Y, Nagai K, Sakuma M, et al. Ambulatory blood pressure of adults in Ohasama, Japan. Hypertension. 1993;22(6):900-912. doi:10.1161/01.hyp.22.6.900
Mancia G, Sega R, Grassi G, Cesana G, Zanchetti A. Defining ambulatory and home blood pressure normality: further considerations based on data from the PAMELA study. J Hypertens. 2001;19(6):995-999. doi:10.1097/00004872-200106000-00001
Muntner P, Carey RM, Jamerson K, Wright JT Jr., Whelton PK. Rationale for Ambulatory and Home Blood Pressure Monitoring Thresholds in the 2017 American College of Cardiology/American Heart Association Guideline. Hypertension. 2019;73(1):33-38. doi:10.1161/HYPERTENSIONAHA.118.11946
Schettini C, Bianchi M, Nieto F, Sandoya E, Senra H. Ambulatory blood pressure: normality and comparison with other measurements. Hypertension Working Group. Hypertension. 1999;34(4 Pt 2):818-825. doi:10.1161/01.hyp.34.4.818
Ohkubo T, Imai Y, Tsuji I, et al. Reference values for 24-hour ambulatory blood pressure monitoring based on a prognostic criterion: the Ohasama Study. Hypertension. 1998;32(2):255-259. doi:10.1161/01.hyp.32.2.255
European Society of Hypertension-European Society of Cardiology Guidelines C. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21(6):1011-1053. doi:10.1097/00004872-200306000-00001
O'Brien E, Asmar R, Beilin L, et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens. 2003;21(5):821-848. doi:10.1097/00004872-200305000-00001
Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25(6):1105-1187. doi:10.1097/HJH.0b013e3281fc975a
Mancia G, Omboni S, Parati G, et al. Twenty-four hour ambulatory blood pressure in the Hypertension Optimal Treatment (HOT) study. J Hypertens. 2001;19(10):1755-1763. doi:10.1097/00004872-200110000-00008
Parati G, Omboni S, Mancia G. Difference between office and ambulatory blood pressure and response to antihypertensive treatment. J Hypertens. 1996;14(6):791-797. doi:10.1097/00004872-199606000-00016
Head GA, Mihailidou AS, Duggan KA, et al. Definition of ambulatory blood pressure targets for diagnosis and treatment of hypertension in relation to clinic blood pressure: prospective cohort study. BMJ. 2010;340:c1104. doi:10.1136/bmj.c1104
Thijs L, Staessen JA, Celis H, et al. The international database of self-recorded blood pressures in normotensive and untreated hypertensive subjects. Blood Press Monit. 1999;4(2):77-86.
Niiranen TJ, Asayama K, Thijs L, et al. Outcome-driven thresholds for home blood pressure measurement: international database of home blood pressure in relation to cardiovascular outcome. Hypertension. 2013;61(1):27-34. doi:10.1161/HYPERTENSIONAHA.111.00100
Kario K, Saito I, Kushiro T, et al. Home blood pressure and cardiovascular outcomes in patients during antihypertensive therapy: primary results of HONEST, a large-scale prospective, real-world observational study. Hypertension. 2014;64(5):989-996. doi:10.1161/HYPERTENSIONAHA.114.04262
Vongpatanasin W, Ayers C, Lodhi H, et al. Diagnostic thresholds for blood pressure measured at home in the context of the 2017 hypertension guideline. Hypertension. 2018;72(6):1312-1319. doi:10.1161/HYPERTENSIONAHA.118.11657
Miao H, Yang S, Zhang Y. Differences of blood pressure measured at clinic versus at home in the morning and in the evening in Europe and Asia: a systematic review and meta-analysis. J Clin Hypertens (Greenwich). 2022;24(6):677-688. doi:10.1111/jch.14487
Kjeldsen SE, Hedner T, Jamerson K, et al. Hypertension optimal treatment (HOT) study: home blood pressure in treated hypertensive subjects. Hypertension. 1998;31(4):1014-1020. doi:10.1161/01.hyp.31.4.1014
Zhang W, Zhang S, Deng Y, et al. Trial of intensive blood-pressure control in older patients with hypertension. N Engl J Med. 2021;385(14):1268-1279. doi:10.1056/NEJMoa2111437
Zhang WL, Cai J. STEP to blood pressure management of elderly hypertension: evidence from Asia. Hypertens Res. 2022;45(4):576-582. doi:10.1038/s41440-022-00875-7
Stergiou G, Kollias A, Parati G, O'Brien E. Office blood pressure measurement: the weak cornerstone of hypertension diagnosis. Hypertension. 2018;71(5):813-815. doi:10.1161/HYPERTENSIONAHA.118.10850
Seo J, Lee CJ, Oh J, Lee SH, Kang SM, Park S. Large discrepancy between unobserved automated office blood pressure and ambulatory blood pressure in a high cardiovascular risk cohort. J Hypertens. 2019;37(1):42-49. doi:10.1097/HJH.0000000000001868
Chow CK, Atkins ER, Hillis GS, et al. Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial. Lancet. 2021;398(10305):1043-1052. doi:10.1016/S0140-6736(21)01922-X
Drawz PE, Pajewski NM, Bates JT, et al. Effect of intensive versus standard clinic-based hypertension management on ambulatory blood pressure: results from the SPRINT (Systolic Blood Pressure Intervention Trial) ambulatory blood pressure study. Hypertension. 2017;69(1):42-50. doi:10.1161/HYPERTENSIONAHA.116.08076
Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet. 1998;351(9118):1755-1762. doi:10.1016/s0140-6736(98)04311-6
Mancia Chairperson G, Kreutz Co-Chair R, Brunstrom M, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the European Renal Association (ERA) and the International Society of Hypertension (ISH). J Hypertens. 2023. doi:10.1097/HJH.0000000000003480
Lee HY, Shin J, Kim GH, et al. 2018 Korean Society of Hypertension Guidelines for the management of hypertension: part II-diagnosis and treatment of hypertension. Clin Hypertens. 2019;25:20. doi:10.1186/s40885-019-0124-x
(UK) NCGC. Hypertension: The Clinical Management of Primary Hypertension in Adults: Update of Clinical Guidelines 18 and 34. London: Royal College of Physicians (UK); 2011.
Cheng YB, Thijs L, Zhang ZY, et al. Outcome-driven thresholds for ambulatory blood pressure based on the New American College of Cardiology/American Heart Association Classification of Hypertension. Hypertension. 2019;74(4):776-783. doi:10.1161/HYPERTENSIONAHA.119.13512
Shimbo D, Artinian NT, Basile JN, et al. Self-measured blood pressure monitoring at home: a joint policy statement from the American Heart Association and American Medical Association. Circulation. 2020;142(4):e42-e63. doi:10.1161/CIR.0000000000000803
Kario K. Key points of the 2019 Japanese Society of Hypertension guidelines for the management of hypertension. Korean Circ J. 2019;49(12):1123-1135. doi:10.4070/kcj.2019.0246
Canada H. A Practical Guide informed by the Hypertension Canada Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension; 2020.
Aparicio LS, Thijs L, Boggia J, et al. Defining thresholds for home blood pressure monitoring in octogenarians. Hypertension. 2015;66(4):865-873. doi:10.1161/HYPERTENSIONAHA.115.05800
Nerenberg KA, Zarnke KB, Leung AA, et al. Hypertension Canada's 2018 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults and children. Can J Cardiol. 2018;34(5):506-525. doi:10.1016/j.cjca.2018.02.022
Mancia G, Facchetti R, Seravalle G, Cuspidi C, Corrao G, Grassi G. Adding home and/or ambulatory blood pressure to office blood pressure for cardiovascular risk prediction. Hypertension. 2021;77(2):640-649. doi:10.1161/HYPERTENSIONAHA.120.16303
Wang TD, Chiang CE, Chao TH, et al. 2022 guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the management of hypertension. Acta Cardiol Sin. 2022;38(3):225-325. doi:10.6515/ACS.202205_38(3).20220321A